Stock Markets March 24, 2026

National Vision’s Strategic Shift Boosts Revenue, Margins, and Product Mix

CEO outlines move toward managed care, smart eyewear adoption, technology investments and measured store growth as drivers of profitability

By Marcus Reed
National Vision’s Strategic Shift Boosts Revenue, Margins, and Product Mix

National Vision has seen a significant stock rally and improved financial performance driven by a deliberate pivot toward managed-care customers, higher-value product assortment including smart eyewear, and a technology-led modernization of its in-store experience. CEO Alex Wilkes says the company is reallocating marketing and reshaping assortment and mix to capture customers who deliver larger average transactions while maintaining the company’s value positioning for cash-pay shoppers.

Key Points

  • Managed-care customers now represent nearly 42% of sales, providing much higher average transaction values - retail and healthcare services impact.
  • Operating margins expanded 160 basis points year-over-year in fiscal 2025, and management targets 50-150 basis points of further expansion between 2026 and 2030 - affects corporate profitability and retail margins.
  • Smart eyewear and premium lens attach rates are boosting transaction value; rollout of Ray-Ban Meta has shown strong SKU velocity - impacts consumer technology and specialty retail segments.

National Vision’s shares have captured investor attention after a steep rise of roughly 120% over the past 12 months, helped by accelerating top-line growth, expanding margins and its strongest annual earnings per share since 2022. The company also posted another solid earnings beat in its most recent quarter, underscoring execution on a strategic transition that management says is starting to pay off.

I spoke with the company’s chief executive, Alex Wilkes, to dissect the drivers behind the improved results, to understand how a major change in customer mix is being implemented and to assess the path ahead for one of the larger optical retailers in the U.S. His comments focused on the math of the company’s managed-care pivot, the role of product mix in margin expansion, the emerging contribution from smart eyewear and the operational investments being made in technology and store growth planning.


The managed-care recalibration

For years National Vision’s operating model centered on a clear, value-oriented offer: two pairs of glasses plus an eye exam for $95. That bundle resonated strongly with customers who pay cash out of pocket, but it left a sizable and growing segment of insured consumers underpenetrated. Management says the company is deliberately shifting to capture a larger share of managed-care customers, even if that means dialing back some of the resources historically devoted to cash-pay acquisition.

Wilkes explained the economic rationale. He noted that a managed-care patient typically applies a frame allowance in the $130 to $150 range, and that the average managed-care transaction can be 2.4 to 4.0 times the value of the entry-level bundle. That change in ticket size matters: managed care now represents nearly 42% of National Vision’s sales, and the company is repositioning marketing and assortment to reach the higher-value segment while continuing to serve cash-pay shoppers.

As Wilkes put it, “Historically, our business skewed heavily toward cash-pay customers, which was effective when insurance benefits represented a smaller share of category spend. As managed care has now grown to account for a larger portion of both the market and our own business, we are intentionally evolving our approach.” He added that the company is not abandoning its value roots: the strategy is to expand share where National Vision is underpenetrated relative to the category.

Early indications of the strategy’s impact on unit volumes are notable. In a market where eye exams declined in the mid-to-high single digits last year, National Vision grew exams by roughly 1%, reflecting the company’s ability to maintain and modestly expand service volumes even as it shifts focus toward higher-ticket customers.


Why margins can keep improving

A common concern with higher managed-care penetration is that some managed-care products can carry lower gross margin rates than entry-level cash bundles. Wilkes urged a dollars-first view: the emphasis should be on gross margin dollars and operating leverage rather than on margin percentages alone. He pointed out that average revenue per transaction from managed-care customers is considerably greater, which helped push gross margins up by about 40 basis points in the company’s most recent fourth quarter.

Operating profitability has shown tangible improvement as well. Operating margins expanded by 160 basis points year-over-year in fiscal 2025. Looking forward, Wilkes expects operating margin expansion of roughly 50 to 150 basis points between 2026 and 2030. Management’s plan to achieve that includes increasing the share of premium frames to about 60% of the assortment by the end of 2026, improving premium lens attach rates and growing smart eyewear penetration.

“While some managed-care products carry lower margin rates, overall profitability improves due to higher tickets and mix,” Wilkes said. In other words, the company is banking on larger average transactions and a shift toward higher-margin items within the broader assortment to generate incremental margin dollars and operating leverage.


Smart eyewear as a revenue and margin multiplier

Smart eyewear features prominently in National Vision’s growth story. The company’s rollout of Ray-Ban Meta across its estate has been described as highly successful, with the SKU turning faster than nearly any other item in its assortment. Beyond velocity, smart eyewear and upgraded lens options materially increase transaction value: early results show high premium lens attachment rates on these skus, making them among the highest-value transactions the company handles.

Wilkes indicated a desire to broaden the assortment and become an “agnostic destination” for smart eyewear customers, welcoming potential relationships with other tech companies to expand choice. The thesis here is that technology-enabled eyewear and premium lenses lift both revenue per visit and margin dollars by changing the mix and elevating attach rates.


Technology, stores and the cadence of growth

Alongside assortment changes, National Vision is executing a technology upgrade aimed at modernizing a sector that historically leans on analog processes - from in-store eye exams to lens selection. Management believes integrating digital tools will improve access, personalization and the overall patient experience, supporting both conversion and higher attach rates.

The company plans to expand its physical footprint in a measured way. For the current year, management has planned a modest rollout of 30 to 35 new locations while reserving the option for a more aggressive expansion in 2028 once the technology overhaul is largely complete. The staged approach reflects a desire to balance capacity growth with the timing of operational upgrades that should enable better returns from new stores.


Investor focus and execution risk

Investors tracking the name will be watching whether the managed-care momentum and product-mix shifts can continue to drive operating leverage, revenue growth and margin expansion. The stock is trading near the top of its four-month range and management has posted a solid Q1 beat, creating expectations that the strategic moves are taking hold.

Wilkes framed the initiative as an ongoing transformation: "We’re continuing to successfully execute on our transformation plan, adjusting customer acquisition strategies, product assortment, mix and marketing to build a healthier, more durable business." The next phase will test whether the company can sustain the gains in profitability and translate early successes in smart eyewear and managed-care penetration into lasting financial improvement.


Conclusion

National Vision’s repositioning toward higher-value managed-care customers, the rapid adoption of smart eyewear and an array of technology and merchandising investments outline a clear path management believes will expand gross margin dollars and operating profits. The outcome will hinge on execution - in marketing reallocation, assortment optimization, store rollout and technology deployment - as the company seeks to convert initial momentum into long-term, durable growth.

Risks

  • Some managed-care products can have lower gross margin rates even as managed-care penetration increases, which could pressure margin rates if mix shifts unfavorably - impacts retail gross margins and healthcare reimbursement dynamics.
  • Reallocating marketing away from cash-pay customers risks reducing traffic from longtime value shoppers if the managed-care strategy does not fully offset those volumes - impacts retail foot traffic and same-store performance.
  • Execution risk tied to technology upgrades and the timing of store expansion: a modest rollout of 30-35 new locations is planned this year with potential for larger expansion after a refresh, so delays or implementation issues could constrain expected operating leverage - affects capital spending and retail operations.

More from Stock Markets

BofA Flags Five U.S. Cleantech Names as Solar Cost Advantages Persist Mar 24, 2026 Apple to Start Selling Ads in Maps in U.S. and Canada This Summer Mar 24, 2026 Fundrise Innovation Fund Shares Surge Again, Trading at Huge Premium to NAV Mar 24, 2026 Newly Listed VCX Rockets on Anthropic Stake and Claude Buzz Mar 24, 2026 BofA Reinstates Buy on Microsoft, Sees AI-Driven Revenue Lift and 31% Upside Mar 24, 2026